FIELD: medicine, pharmacy.
SUBSTANCE: this invention refers to a sustained-release pill containing levodropropizine with antitussive and expectorant effect. The presented levodropropizine sustained-release pill consists of: an immediate release layer comprising levodropropizine and a sustained release layer comprising levodropropizine and a release controlling polymer.
EFFECT: invention extends the product range of pharmaceuticals with delayed release.
3 cl, 4 tbl, 2 ex, 6 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| SUSTAINED-RELEASED ACECLOFENAC PREPARATION EXHIBITING FAST ANALGESIC AND ANTI-INFLAMMATORY ACTION POSSESSING OPTIMUM PHARMACOLOGICAL AND CLINICAL ACTION IF ADMINISTERED ONCE A DAY | 2011 |
|
RU2540471C2 |
| LENALIDOMIDE TABLET COMPOSITION FOR ORAL ADMINISTRATION | 2017 |
|
RU2725074C1 |
| ORAL PREPARATION WITH SUSTAINED RELEASE | 2015 |
|
RU2696870C2 |
| COMPOSITIONS OF PILL WITH IMMEDIATE RELEASE | 2010 |
|
RU2558798C2 |
| PHARMACEUTICAL COMPOSITION FOR COMBINATION OF PIPERIDINE ALKANOL WITH ANTIEDEMIC AGENT | 1998 |
|
RU2207879C2 |
| PHARMACEUTICAL COMPOSITION IN FORM OF SINGLE ORAL DOSE CONTAINING LEVODOPA, CARBIDOPA AND ENTACAPONE, OR SALTS THEREOF | 2009 |
|
RU2519159C2 |
| ACECLOFENAC-CONTAINING CONTROL RELEASE ORAL DOSAGE FORMS AND METHOD FOR PREPARING THEM | 2009 |
|
RU2493843C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING CELECOXIB AND TRAMADOL | 2016 |
|
RU2710370C2 |
| AGENT BASED ON DRY MOTHERWORT EXTRACT AND METHOD FOR PRODUCTION THEREOF | 2015 |
|
RU2589507C1 |
| EXTENDED-RELEASE PHARMACEUTICAL COMPOSITION CONTAINING LACOSAMIDE | 2019 |
|
RU2808425C2 |
